Pfizer Scores FDA Nod For Hemophilia B Gene Therapy, Will Charge $3.5M Per Dose - FiercePharma- AGK News Stand

Pfizer scores FDA nod for hemophilia B gene therapy, will charge $3.5M per dose - FiercePharma

Card image cap